Chiesi Agrees to Buy KalVista Pharmaceuticals for $1.9 Billion
✨ AI Summary
🔊 جاري الاستماع
Chiesi Farmaceutici SpA agreed to acquire US-listed KalVista Pharmaceuticals Inc. for about $1.9 billion in its biggest acquisition to date, expanding the Italian company’s rare immunology portfolio.
